Review of Toxic Epidermal Necrolysis (Q28074097)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

6 references

31 August 2020

20 December 2020

1 February 2021

15 September 2022

3 October 2022

28 October 2022

Review of Toxic Epidermal Necrolysis (English)

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

0 references

0 references

Stevens–Johnson syndrome

14 references

12 March 2019

13 March 2019

21 March 2019

18 June 2019

22 June 2019

19 June 2019

17 June 2019

1 August 2019

3 October 2019

11 October 2019

12 October 2019

20 November 2019

27 November 2019

31 August 2020

tumor necrosis factor

2 references

1 August 2019

1 February 2021

1 reference

11 October 2019

1 reference

12 October 2019

1 reference

20 November 2019

1 reference

27 November 2019

1 reference

31 August 2020

1 reference

20 December 2020

toxic epidermal necrolysis

1 reference

inferred from title

author

Christopher J Jackson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

author name string

Victoria Harris

series ordinal

1

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

Alan Cooper

series ordinal

3

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

language of work or name

1 reference

18 December 2016

21 references

12 March 2019

13 March 2019

21 March 2019

18 June 2019

22 June 2019

19 June 2019

17 June 2019

1 August 2019

3 October 2019

11 October 2019

12 October 2019

20 November 2019

27 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

31 August 2020

20 December 2020

1 February 2021

15 September 2022

3 October 2022

28 October 2022

International Journal of Molecular Sciences

20 references

12 March 2019

13 March 2019

21 March 2019

18 June 2019

22 June 2019

19 June 2019

17 June 2019

1 August 2019

3 October 2019

11 October 2019

12 October 2019

20 November 2019

27 November 2019

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

31 August 2020

20 December 2020

1 February 2021

15 September 2022

3 October 2022

28 October 2022

17

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

issue

12

2 references

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

Creative Commons Attribution

30 March 2020

page(s)

2135

0 references

copyright license

19 references

12 March 2019

13 March 2019

21 March 2019

18 June 2019

22 June 2019

19 June 2019

17 June 2019

1 August 2019

3 October 2019

11 October 2019

12 October 2019

20 November 2019

27 November 2019

31 August 2020

20 December 2020

1 February 2021

15 September 2022

3 October 2022

28 October 2022

0 references

on focus list of Wikimedia project

ScienceSource

0 references

cites work

Association of HLA-B*5801 allele and allopurinol-induced stevens johnson syndrome and toxic epidermal necrolysis: a systematic review and meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

A European study of HLA-B in Stevens-Johnson syndrome and toxic epidermal necrolysis related to five high-risk drugs

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

European Guidelines (S1) on the use of high-dose intravenous immunoglobulin in dermatology

20 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

U.K. guidelines for the management of Stevens-Johnson syndrome/toxic epidermal necrolysis in adults 2016.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Retrospective review of Stevens-Johnson syndrome/toxic epidermal necrolysis treatment comparing intravenous immunoglobulin with cyclosporine

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis: Part I. Introduction, history, classification, clinical features, systemic manifestations, etiology, and immunopathogenesis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis: the year in review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

The efficacy of intravenous immunoglobulin for the treatment of toxic epidermal necrolysis: a systematic review and meta-analysis.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

HLA-A*3101 and carbamazepine-induced hypersensitivity reactions in Europeans

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis: retrospective analysis of 21 consecutive cases managed at a tertiary centre.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis: current evidence, practical management and future directions

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Correlations between clinical patterns and causes of erythema multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis: results of an international prospective study

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

SCORTEN: a severity-of-illness score for toxic epidermal necrolysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

IKZF1, a new susceptibility gene for cold medicine-related Stevens-Johnson syndrome/toxic epidermal necrolysis with severe mucosal involvement.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Stevens‐Johnson Syndrome and Toxic Epidermal Necrolysis Are Severity Variants of the Same Disease which Differs from Erythema Multiforme

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany

2 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5187935

A NEW ERUPTIVE FEVER ASSOCIATED WITH STOMATITIS AND OPHTHALMIA

2 June 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Comprehensive survival analysis of a cohort of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Incidence of toxic epidermal necrolysis and Stevens-Johnson Syndrome in an HIV cohort: an observational, retrospective case series study

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Toxic epidermal necrolysis: the past, the guidelines and challenges for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Granulysin is a key mediator for disseminated keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

HLA-A*31:01 and different types of carbamazepine-induced severe cutaneous adverse reactions: an international study and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Methylprednisolone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis: clinical evaluation and analysis of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Toxic epidermal necrolysis: Five years of treatment experience from a burn unit

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Rapid resolution of toxic epidermal necrolysis with anti-TNF-alpha treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Granulocyte colony-stimulating factor in toxic epidermal necrolysis (TEN) and Chelsea & Westminster TEN management protocol [corrected].

21 January 2018

1 reference

https://api.crossref.org/works/10.3390/IJMS17122135

Epidemiology of erythema exsudativum multiforme majus, Stevens-Johnson syndrome, and toxic epidermal necrolysis in Germany (1990-1992): structure and results of a population-based registry

21 January 2018

1 reference

12 December 2020

Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis associated with Mycoplasma pneumoniae infection

1 reference

12 December 2020

The role of intravenous immunoglobulin in toxic epidermal necrolysis: a retrospective analysis of 64 patients managed in a specialized centre

1 reference

12 December 2020

Antitumour necrosis factor-alpha antibodies (infliximab) in the treatment of a patient with toxic epidermal necrolysis

1 reference

12 December 2020

Dexamethasone pulse therapy for Stevens-Johnson syndrome/toxic epidermal necrolysis

1 reference

12 December 2020

Increased soluble Fas ligand levels in patients with Stevens-Johnson syndrome and toxic epidermal necrolysis preceding skin detachment

1 reference

12 December 2020

Blister fluid T lymphocytes during toxic epidermal necrolysis are functional cytotoxic cells which express human natural killer (NK) inhibitory receptors

1 reference

12 December 2020

Stevens-Johnson syndrome and toxic epidermal necrolysis after vaccination: reports to the vaccine adverse event reporting system

1 reference

12 December 2020

Erythema multiforme and toxic epidermal necrolysis: a comparative study

1 reference

12 December 2020

Cutaneous T-cell recruitment in toxic epidermal necrolysis. Further evidence of CD8 lymphocyte involvement

1 reference

12 December 2020

Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

1 reference

12 December 2020

Etanercept therapy for toxic epidermal necrolysis

1 reference

12 December 2020

Toxic epidermal necrolysis: an eruption resembling scalding of the skin

1 reference

12 December 2020

Toxic epidermal necrolysis

1 reference

12 December 2020

Identifiers

DOI

10.3390/IJMS17122135

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27999358 AND SRC:MED&resulttype=core&format=json

30 March 2020

PubMed publication ID

2 references